Literature DB >> 19104799

Healthcare costs for new technologies.

Mathias Goyen1, Jörg F Debatin.   

Abstract

INTRODUCTION: Continuous ageing of the population coupled with growing health consciousness and continuous technological advances have fueled the rapid rise in healthcare costs in the United States and Europe for the past several decades. The exact impact of new medical technology on long-term spending growth remains the subject of controversy. By all measures it is apparent that new medical technology is the dominant driver of increases in health-care costs and hence insurance premiums.
OBJECTIVE: This paper addresses the impact of medical technology on healthcare delivery systems with regard to medical practice and costs. We first explore factors affecting the growth of medical technology and then attempt to provide a means for assessing the effectiveness of medical technology. DISCUSSION: Avoidable healthcare cost drivers are identified and related policy issues are discussed.

Mesh:

Year:  2009        PMID: 19104799     DOI: 10.1007/s00259-008-0975-y

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


  7 in total

1.  Can defined contribution health insurance reduce cost growth?

Authors:  Len M Nichols
Journal:  EBRI Issue Brief       Date:  2002-06

Review 2.  Medical care costs: how much welfare loss?

Authors:  J P Newhouse
Journal:  J Econ Perspect       Date:  1992

3.  Health care spending and use of information technology in OECD countries.

Authors:  Gerard F Anderson; Bianca K Frogner; Roger A Johns; Uwe E Reinhardt
Journal:  Health Aff (Millwood)       Date:  2006 May-Jun       Impact factor: 6.301

4.  The value of medical spending in the United States, 1960-2000.

Authors:  David M Cutler; Allison B Rosen; Sandeep Vijan
Journal:  N Engl J Med       Date:  2006-08-31       Impact factor: 91.245

5.  Cost-effectiveness of FDG-PET for the management of potentially operable non-small cell lung cancer: priority for a PET-based strategy after nodal-negative CT results.

Authors:  M Dietlein; K Weber; A Gandjour; D Moka; P Theissen; K W Lauterbach; H Schicha
Journal:  Eur J Nucl Med       Date:  2000-11

6.  Medical innovation duels cost containment.

Authors:  R A Rettig
Journal:  Health Aff (Millwood)       Date:  1994       Impact factor: 6.301

7.  Cost-effectiveness of FDG-PET for the management of solitary pulmonary nodules: a decision analysis based on cost reimbursement in Germany.

Authors:  M Dietlein; K Weber; A Gandjour; D Moka; P Theissen; K W Lauterbach; H Schicha
Journal:  Eur J Nucl Med       Date:  2000-10
  7 in total
  9 in total

Review 1.  Sequential whole-body PET/MR scanner: concept, clinical use, and optimisation after two years in the clinic. The manufacturer's perspective.

Authors:  Antonis Kalemis; Bénédicte M A Delattre; Susanne Heinzer
Journal:  MAGMA       Date:  2012-08-07       Impact factor: 2.310

2.  MR/PET or PET/MRI: does it matter?

Authors:  Thomas Beyer; Ewald Moser
Journal:  MAGMA       Date:  2013-02-06       Impact factor: 2.310

3.  Healthcare technology: physician collaboration in reducing the surgical cost.

Authors:  Steven A Olson; William T Obremskey; Kevin J Bozic
Journal:  Clin Orthop Relat Res       Date:  2013-06       Impact factor: 4.176

4.  A case study of the counterpart technical support policy to improve rural health services in Beijing.

Authors:  Weiyan Jian; Kit Yee Chan; Shunv Tang; Daniel D Reidpath
Journal:  BMC Health Serv Res       Date:  2012-12-29       Impact factor: 2.655

5.  Medical technology as a key driver of rising health expenditure: disentangling the relationship.

Authors:  Corinna Sorenson; Michael Drummond; Beena Bhuiyan Khan
Journal:  Clinicoecon Outcomes Res       Date:  2013-05-30

6.  The future of hybrid imaging-part 3: PET/MR, small-animal imaging and beyond.

Authors:  Thomas Beyer; Lutz S Freudenberg; Johannes Czernin; David W Townsend
Journal:  Insights Imaging       Date:  2011-03-25

7.  Financial protection of rural health insurance for patients with hypertension and diabetes: repeated cross-sectional surveys in rural China.

Authors:  Xiaoyun Liu; Xiaojie Sun; Yang Zhao; Qingyue Meng
Journal:  BMC Health Serv Res       Date:  2016-09-08       Impact factor: 2.655

8.  Stakeholder value judgments in decision-making on the incorporation, financing, and allocation of new health technologies in limited-resource settings: a potential Brazilian approach.

Authors:  Luiz Santoro; Fernanda Lessa; Elene Paltrinieri Nardi; Marcos Bosi Ferraz
Journal:  Rev Panam Salud Publica       Date:  2018-08-10

9.  Introduction of new technologies and decision making processes: a framework to adapt a Local Health Technology Decision Support Program for other local settings.

Authors:  Paule Poulin; Lea Austen; Catherine M Scott; Michelle Poulin; Nadine Gall; Judy Seidel; René Lafrenière
Journal:  Med Devices (Auckl)       Date:  2013-11-18
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.